RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 109 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $442,329,000 | +67.3% | 49,312 | +0.2% | 0.00% | +100.0% |
| Q2 2016 | $264,403,000 | +21.8% | 49,237 | +4.5% | 0.00% | 0.0% |
| Q1 2016 | $217,000,000 | -11.4% | 47,136 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $245,000,000 | +85564.3% | 47,136 | -0.2% | 0.00% | 0.0% |
| Q3 2015 | $286,000 | -100.0% | 47,218 | -1.8% | 0.00% | -66.7% |
| Q2 2015 | $759,610,000 | +77.5% | 48,107 | +22.2% | 0.00% | +50.0% |
| Q1 2015 | $427,974,000 | +3.3% | 39,372 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $414,193,000 | +5.5% | 39,372 | -3.8% | 0.00% | 0.0% |
| Q3 2014 | $392,528,000 | -17.0% | 40,931 | -0.1% | 0.00% | 0.0% |
| Q2 2014 | $473,100,000 | +16.6% | 40,961 | +1.0% | 0.00% | 0.0% |
| Q1 2014 | $405,660,000 | -21.3% | 40,566 | +2.5% | 0.00% | 0.0% |
| Q4 2013 | $515,488,000 | -7.1% | 39,592 | +6.6% | 0.00% | -33.3% |
| Q3 2013 | $555,126,000 | +64.3% | 37,157 | +2.8% | 0.00% | +50.0% |
| Q2 2013 | $337,965,000 | – | 36,146 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 16,355 | $244,000 | 3.04% |
| EAM Investors, LLC | 175,761 | $2,626,000 | 0.52% |
| Tekla Capital Management LLC | 110,000 | $1,643,000 | 0.18% |
| Jane Street Holding, LLC | 447,456 | $6,676,000 | 0.08% |
| A.R.T. Advisors, LLC | 95,164 | $1,419,000 | 0.08% |
| CREDIT SUISSE AG/ | 5,079,886 | $75,792,000 | 0.08% |
| NOMURA HOLDINGS INC | 736,362 | $10,936,000 | 0.07% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,000 | $14,920,000 | 0.04% |
| ROYAL BANK OF CANADA | 2,971,616 | $44,337,000 | 0.03% |
| LORD, ABBETT & CO. LLC | 721,849 | $10,784,000 | 0.02% |